Some evidence has suggested the existence and differential distribution of neuropeptide Y (NPY) receptor subtypes in the mammalian brain Aicher et al., 1991) . We now report on the extensive characterization and visualization of at least two classes of NPY receptor sites using a highly selective Y, analog, (Leu3',Pro3]-NPY or [Pro"]-NPY, and a relatively specific Y, competitor, NPY,,,,. Autoradiographic studies using '%peptide YY (1251-PYY) clearly reveal that the Y, receptor subtype is most abundant in various cortical areas, the dentate gyrus of the hippocampal formation, the claustrum, and the reuniens nucleus of the thalamus. In most other regions, '251-PYY binding is potently inhibited by increasing concentrations of either NPY.,, or NPY,,,,, suggesting a Y,-like profile. Furthermore, binding assays using homogenates from discrete brain regions clearly demonstrate that various NPY fragments and analogs compete for '%PYY labeling with profiles indicative of heterogeneity of NPY receptor subtypes, even in the presence of a selective Y, blocker. Thus, it is likely that, in addition to the Y, receptor, which is particularly concentrated in cortical areas, the rat brain is enriched with a receptor class (Y,) that can exist under high-or low-affinity states or with additional receptor subtypes that are recognized by V-PYY. These findings cannot be explained by the existence of the very recently reported Y, receptor subtype, since PYY does not possess significant affinity to this site (Grundemar et al., 1991) . Further experiments are currently in progress to determine the nature and functional significance of each of these NPYIPYY receptor sites.
[ Neuropeptide Y (NPY), a 36 amino acid polypeptide isolated from porcine brain, shares important sequence homology with peptide YY (PYY) and various pancreatic polypeptides (PP) (Tatemoto, 1982; Tatemoto et al., 1982) . Therefore, it has been included as a member of the PP family (Tatemoto, 1982; Tatemoto et al., 1982; Emson and DeQuidt, 1984) . Interestingly, NPY is one of the most abundant peptides found in the CNS (Chronwall et al., 1985; O'Donohue et al., 198.5; DeQuidt and Emson, 1986a,b) . NPY-like immunoreactivity is especially concentrated in various regions of the limbic system including certain cortical areas, the hippocampal formation, the amygdaloid nuclei, and the hypothalamus (Chronwall et al., 1985; O'Donohue et al., 1985; DeQuidt and Emson, 1986a,b) . Moreover, in situ hybridization studies have revealed that the distribution of NPY mRNA correlates rather well with that of NPY-likeimmunoreactive material (Terenghi et al., 1987; Chan-Palay et al., 1988) . Many studies have demonstrated the existence of specific receptors for NPY and related peptides in mammalian brain (Chang et al., 1985 (Chang et al., , 1986 (Chang et al., , 1988 Saria et al., 1985; Martel et al., 1986 Martel et al., , 1987 Martel et al., , 1988 Martel et al., , 1990a Inui et al., 1988 Inui et al., , 1989 Busch-Sorensen et al., 1989; Lynch et al., 1989; Sheikh et al., 1989a,b; Ohkubo et al., 1990; Rosier et al., 1990; Sheikh and Williams, 1990; Dumont et al., 1992; Quirion and Martel, 1992) . Using anatomical methods, it was shown that NPY binding sites are concentrated mostly in the hippocampal formation, various cortical areas, the olfactory bulb, and the lateral septum. Lower but still highly significant densities of NPY sites are also present in the striatum, in various thalamic, hypothalamic, and brainstem nuclei, and in the cerebellum (Martel et al., 1986 (Martel et al., , 1987 (Martel et al., , 1988 (Martel et al., , 1990a Inui et al., 1989; Lynch et al., 1989; Ohkubo et al., 1990; Rosier et al., 1990) . The overall anatomical distribution observed using a variety of radioligands including 'H-NPY, 1251-Bolton-Hunter-NPY, or l*sI-PYY is similar. However, some differences were detected in certain hypothalamic and brainstem nuclei as well as in the cerebellum (Lynch et al., 1989; Martel et al., 1990a; , suggesting the possible heterogeneity of NPY receptors in the mammalian brain.
This concept is also supported by functional studies. As early as 1986, Wahlestedt and coworkers suggested the existence of two classes of NPY receptors (Y, and YZ) in peripheral tissues. They observed that while the full NPY/PYY sequence was required to act upon the Y, receptor, C-terminal fragments such as NPY,,.,, and PYY,,.,, were able to activate the Y, subtype fully, albeit with lower potencies than the native peptides (Wahlestedt et al., 1986) . In the CNS, NPY acts to stimulate food and water intake, probably via Y, receptors since various C-terminal fragments were inactive in this paradigm (Danho et al., 1988; Flood and Morley, 1989; Jolicoeur et al., 199 1a.b; Leibowitz and Alexander, 1991) . In contrast, the facilitation of memory retention induced by NPY is most likely related to the activation of YZ receptors (Flood and Morley, 1989) . The effects of these peptides on locomotor behaviors and various cardio-vascular parameters are either inhibitory or stimulatory depending upon the activation of one of these two receptor types (Heilig and Murison, 1987; Heilig et al., 1988; Aguirre et al., 1990) . There is a possibility that these two receptor classes are coupled to different transduction mechanisms, the Y, sites being coupled to phosphoinositol turnover (Wahlestedt, 1987; Hinson et al., 1988; Widdowson and Halaris, 1990a ) and the Y, receptor being linked to the activity of adenylate cyclase (Harfstrand et al., 1987; Petrenko et al., 1987; Wahlestedt, 1987; WestlindDanielsson et al., 1987 WestlindDanielsson et al., , 1988 Widdowson and Halaris, 1990b) . More recently, the existence of yet another receptor class (Y,) was proposed on the basis that certain effects induced by NPY are shared by both Y, and Y, agonists but not by the homolog PYY (Grundemar et al., 199 1; Wahlestedt et al., 1992) . Rimland et al. (1991) have just reported the cloning of a G-proteincoupled receptor that could represent that new NPY receptor class, although this remains to be fully established.
In a previous study, we provided preliminary evidence for the differential distribution of Y, and Y, receptors in the rat brain (Fuhlendorff et al., 1990a,b; Schwartz et al., 1990) and Y,-preferential fragments. However, the precise proportion of each receptor subtype in a given brain region was not established.
Moreover, it is still unclear if these two broad classes of NPY receptors constitute a homogeneous population of sites or if they include other putative subtypes.
Consequently, the aim of the present study was to investigate, in detail, the respective autoradiographic distribution of Y, and Y, receptors in the rat brain. Competition binding profiles using various selective NPY-related peptides clearly suggest further heterogeneity of NPY receptors in the rat brain.
were then placed in x-ray cassettes and apposed against Hype&m for 6 d. Films were developed and analyzed using the standard procedure described by Martel et al. (1990a) .
Membrane binding assays. Membrane binding assays were performed as previously described (Martel et al., 1986 (Martel et al., , 1990b . Briefly, rats were killed by decapitation and their brains rapidly removed; the olfactory bulb, frontoparietal cortex, striatum (including the lateral septum), hippocampus, and cerebellum were rapidly dissected on ice and then homogenized in KRP buffer using a Brinkman polytron (at setting 6 for 15-20 set) and centrifuged at 49,000 x g for 15 min. Supematants were discarded and pellets washed, resuspended, and recentrifuged. Final pellets from the olfactory bulb, the frontoparietal cortex, and the hippocampus obtained from four animals and from the striatum and the cerebellum from eight rats were rinsed and resuspended in 50 ml of KRP buffer each.
Binding assays were initiated by adding 100 ~1 of membrane preparations in a final volume of 500 ~1 of KRP buffer containing 0.1% bovine serum albumin, 0.05% bacitracin, 20-25 PM 'Z51-PYY, and various competitors (pNPY, PYY, NPY, ., , , NPY, , ., , , or [Lcu3', Pro'4] -NPY) at concentrations varying from lo-I2 to 10mh M. Following a 2 hr incubation period at 25°C the reaction was terminated by rapid filtration through Schleicher and Schull #32 filters (previouslv soaked in I .O% oolvethvleneimine) using a cell harvester'filtering apparatus (Brandel Instruments, Gaithersburg, MD). Filters were rinsed three times with 3 ml of cold KRP buffer and dried, and the radioactivity remaining on filters was quantified using a gamma counter (LKB Instruments) with 70% efficiency. The percentage of specifically bound 1L51-PYY was determined as the difference in binding observed in the presence and absence of 1 PM unlabeled pNPY and represented between 80% and 90% of total binding.
Binding data were analyzed using the LUNDON SO~WARE competition program. Individual competition binding curves were fitted to both a one-and a two-binding-site model. If the p value was less than 0.05 on the Fisher test, a two-site model was accepted as representing the best fit for the data. AI1 values are expressed as percentage of specific binding and represented as the mean * SEM of four to eight individual experiments determinations, with each point done in triplicate.
Materials and Methods
Materials. Male Sprague-Dawley CD rats (200-250 gm) obtained from Charles River Canada (St-Constant, Quebec, Canada) were maintained on a 12 hr lightdark cycle (light on at 7:00 AM) in temperature-and humidity-controlled rooms. Animals were fed standard laboratory chow and had access to tap water ad hbidum. Animal care was according to protocols and guidelines approved by McGill University and the Canadian Council for Animal Care.
Analogs and fragments of porcine NPY (pNPY) were synthesized in our laboratories as previously described (Forest et al., 1990; Mattel et al., 1990b) . 'ZsI-PYY (2200 Ci/mmol) was obtained from New England Nuclear-DuPont (Boston, MA), and film (Hyperfilm) and lzsI standards were purchased from Amersham Canada Ltd. (Oakville, Ontario, Canada). All other chemicals were of analytical grade and were obtained from Fisher Scientific Co. (Montreal. Ouebec. Canada) or Siama Chemical Co. (St. Louis, MO).
-' -Receptor autoradiography. Receptor autoradiography was performed as recently described by our group (Mattel et al., 1990a) . Briefly, rats were killed by decapitation, and their brains were rapidly removed from the skull, frozen in 2-methylbutane at ~40°C for 15 set, and then kept at -80°C until needed. Sections (20 pm) were obtained using a Bright cryomicrotome at -17°C before being mounted on gelatin-chromealum-coated slides, dried overnight in a desiccator at 4°C and then kept at -80°C until use.
On the day of the experiments, adjacent coronal brain sections were preincubated for 60 min at room temperature in a Krebs-Ringer phosphate buffer (KRP) at pH 7.4 and then incubated for 120 min in a fresh preparation of KRP buffer supplemented with 0.1% (w/v) bovine serum albumin, 0.05% (w/v) bacitracin, and 25 PM 1*51-PYY in the presence or absence ofeither NPY,,,, NPY,,~,,, or [ProX4]-NPY at concentrations ranging from 10 9 to 10m6 M. Nonspecific binding was determined using adjacent sections incubated in the presence of 1 PM unlabeled porcine NPY (pNPY). At the end ofthe incubation period, sections were washed four times (4 min each) in ice-cold buffer, dipped in deionized water to remove salts, and rapidly dried under a stream of cold air. Sections
Results
Comparative autoradiographic distribution of NPY receptor subtypes As reported earlier (Lynch et al., 1989; Mattel et al., 1990a) , the total population of 1251-PYY receptor binding sites is widely but discretely distributed in the rat brain (Figs. 14). Autoradiographic data obtained at the level of the olfactory bulb ( Fig.  l) , striatum ( Fig. 2) hippocampal formation ( Fig. 3 ) and cerebellum (Fig. 4) show that 12sI-PYY bound with high specificity to NPY/PYY receptor sites as indicated by the absence of labeling in the presence of a saturating concentration of pNPY. High levels of specific lzsI-PYY binding are present in all parts of the anterior olfactory nuclei (Fig. 1 , Table l), the superficial layers of the cortex (Figs. 1-3, Table l), the lateral septum (Fig.  2 , Table l), the piriform cortex, and the oriens layer and stratum radiatum of the hippocampus (Fig. 3 , Table 1 ). Areas such as the striatum (Fig. 2 , Table l), the cerebellum (Fig. 4 , Table l), and most brainstem nuclei (Fig. 4 , Table 1 ) contained relatively moderate to low amounts of lzSI-PYY binding.
The fragment NPY,.,, inhibited, in a concentration-dependent manner, lzSI-PYY binding without obvious specificity for a given brain region or nucleus . At a concentration of 10m6 M, NPY,.,, fully competed for '251-PYY binding sites in all areas including the cingulum, frontal, and orbital cortices and the anterior olfactory nuclei (Fig. 1) ; the frontoparietal cortex, claustrum, striatum, and lateral septum (Fig. 2) ; the hippocampus, piriform cortex, and various thalamic and hypothalamic nuclei (Fig. 3) ; as well as the cerebellum and various brainstem nuclei (Fig. 4) .
In contrast, the specific Y, agonist NPY in the frontoparietal cortex and the claustrum but not in the caudate putamen, the lateral septum, and cortical areas below the rhinal sulcus (Fig. 2, Table 1 ). Almost the opposite situation is observed with the fragment NPY,,.,,, with lz51-PYY labeling being displaced by low concentrations of this competitor in the striatum and the septum but not in cortical areas (Fig. 2, Table 1 ).
At the level of the hippocampal formation (Fig. 3 , Table I ), lz51-PYY labeling is again inhibited by the Y, agonist in cortical areas, while binding in the amygdaloid body and most subcortical structures is resistant to inhibition by [ProJ4]-NPY. In contrast, lz51-PYY labeling in the oriens layer and the stratum radiatum of the hippocampus as well as in the stria terminalis is highly sensitive to increasing concentrations of the Y, fragment (Fig. 3, Table 1 ). However, '251-PYY binding in the dentate gyrus is not effected by NPY,,-,, but very sensitive to the Y, agonist, even at low nanomolar concentrations (Fig. 3, Table 1 ). Thus, lz51-PYY sites in the dentate gyrus are most likely of a different subtype to those present in other sectors of the hippocampal formation. Most lz51-PYY binding sites in thalamic and hypothalamic nuclei are apparently more sensitive to the Y, than the Y, competitor (Fig. 3, Table 1 ). An exception is seen in the reuniens, posterior and laterodorsal thalamic nuclei, which are apparently enriched with [Pro'4]-NPY/Y, sites, whereas the habenular, interanteromedial, ventroposterior, and mediodorsal thalamic nuclei, and the lateral, dorsomedial and ventromedial hypothalamic nuclei are enriched with the Y, subtype (Fig. 3, Table I ).
As in the olfactory bulb (Fig. l) , '251-PYY binding in the cerebellum and various brainstem nuclei (Fig. 4) was found to be more susceptible to inhibition by NPYZ.J6 than by the shorter fragment NPY,,.,,. The Y, agonist was much weaker than the two NPY fragments in these same areas, Characterization of 'z51-PYY binding sites in membranes from rat brain homogenates Membranes prepared from various regions of the rat brain revealed that the homologs PYY and NPY, the fragments NPY,. 36 and NPY,,.,,, and the analog [LeuZ1,Pro34]-NPY inhibited specific 1z51-PYY binding in a concentration-dependent manner (Figs. 5,6 ). The rank order of potency in olfactory bulb, striatal, hippocampal, and cerebellar homogenates revealed PYY > NPY > NPY 2-x 2 NPY,,.,, B [LeuXl,Pro'4]-NPY (Fig. 5) . A different profile of competition was detected in the frontoparietal cortex (Fig. 6) . In this preparation, a clearly biphasic profile is seen with the Y, agonist [Leu3i,Pro34]-NPY. At low concentrations (nanomolar), the ligand selectivity pattern showed PYY > NPY = [Leu3',Pro34]-NPY > NPYZ.,, > NPY,,.,,, while at higher concentrations (micromolar), the Y, agonist was only weakly active, with PYY > pNPY > NPY,,, 2 NPY,,,, > [Lcu3',Pro34]-NPY (Fig. 6 ). This is also clearly shown in Figure 7 . For example, while the competition profile of the fragment NPY,,.,, appears to be identical in membranes prepared from either the olfactory bulb, striatum, hippocampus, or cerebellum, it was much less potent in cortical preparations (Fig. 7A) . In contrast, the Y, agonist [Leu31,Pro34]-NPY inhibited 1z51-PYY binding with a clearly biphasic profile, especially in the frontoparietal cortex area, and to a lesser extent in the olfactory bulb (Fig. 7B) . This suggests the existence ofdifferent classes or affinity states of Iz51-PYY binding sites in these brain regions. The low Hill coefficient values observed for all competitors also supports this hypothesis (Tables 2-6). Data (means ? SEM of four to six determinations) were fitted to a one-or a two-binding-site model by a nonlinear method of analysis using the Lundon Software COMPETITION data analysis program. The goodness of fit between the two models was tested by F test (p < 0.05). n,, represents the Hill coefficient determined by a linear method of analysis. C,, and K,,? represent the affinity of PYY for the high-and low-affinity site, respectively. J&/K,, is the ratio of the affinities of the two binding sites. % R 1 represents the percentage of sites in the high-affinity mode. In fact, binding data were all best fitted using a two-site model as for the low-affinity binding components in all membrane (p < 0.05). The apparent affinities (K,) of the high-and lowpreparations except the frontoparietal cortex; in this tissue, a affinity components detected using PYY itself varied between greater (15fold) decrease is observed for the low-affinity site 4-24 PM and 340-l 350 PM, depending upon the regions studied (Table 4) . Interestingly, the shorter C-terminal fragment NPY,,,, (Table 2) . Similar results were obtained with NPY (Table 3) . demonstrated different affinities for the two binding components The deletion of the tyrosine residue in position 1 (NPY,,,) depending upon the brain region studied. In striatal and hipdecreased the affinity by three-to fivefold for the high-as well pocampal membrane homogenates, NPY ,3.36 possessed rela- tively similar affinities for the two binding components (Table  5) , while important differences were detected in the olfactory bulb (30-fold) and the cerebellum (over 60-fold) (Table 5 ). An even greater dissociation (almost lOO-fold) between the highand low-affinity binding components is observed for the frontoparietal cortex (Table 5) . Moreover, the apparent affinities of the Y, agonist [Leu31,Pro34]-NPY for the high-and low-affinity binding components are dramatically different with values in the sub-to low nanomolar range on the first binding site but only in the micromolar range for the second portion of the competition curves (Table 6 ). This is especially evident in the frontoparietal cortex, a region enriched with the putative Y, receptor subtype (Table 6 ). In the other regions, the proportion of Y, sites is apparently smaller, the lowest amount being detected in the hippocampal formation (Table 6 ). In order to investigate further the possible heterogeneity of l*SI-PYY-labeled binding sites, we performed a series of experiments in the presence of 10 nM [Leu31,Pro34]-NPY, a concentration known to be sufficient to block most, if not all, binding to the Y, site (Figs. 5,7B, Table 6 ). Under such assay conditions, the competition profile is still best fitted to a two-site model (p < 0.05) in regions such as the hippocampus and the striatum (Table 7) . Similarly, Hill coefficients remained below unity, suggesting further heterogeneity of 12SI-PYY-labeled sites in these regions, even in the presence of a saturating concentration of the Y, blocker. Data (means k SEM of four or five determinations) were fitted to a one-or a two-binding-site model by a nonlinear method of analysis using the Lundon Software COMPETITION data analysis program. The goodness of fit between the two models was tested by F test (p < 0.05). n,, represents the Hill coefficient determined by a linear method of analysis. K,, and I&, represent the affinity of NPY i ,e for the high-and low-affinity site, respectively. K&K,,, is the ratio of the affinities of the two binding sites. % RI represents the percentage of sites in the high-affinity mode. Data (means k SEM of four to six determinations) were fitted to a one-or a two-binding-site model by a nonlinear method of analysis using the Lundon Software COMPETITION data analysis program. The goodness of fit between the two models was tested by F test (p < 0.05). n,, represents the Hill coefficient determined by a linear method of analysis. K,, and K,,, represent the affinity of NPY ,, ,h for the high-and low-affinity site, respectively. K,,,/K,, is the ratio of the affinities of the two binding sites. % RI represents the percentage of sites in the high-affinity mode.
Discussion
The major finding of the present study relates to the clear demonstration of the differential distribution of the Y, and Y, NPY receptor subtypes in the rat brain. For example, Y, receptors are especially concentrated in cortical areas while one of the highest proportions of Y, sites is seen in the hippocampal formation. Moreover, the apparent resistance of 1251-PYY-labeled sites to inhibition by [ProJ4]-NPY (Y,) and NPY,,.,, (Y,), but not NPYZ~36r in the olfactory bulb suggests further receptor heterogeneity. As reported earlier (Inui et al., 1988 (Inui et al., , 1998 Lynch et al., 1989; Martel et al., 1990a; Rosier et al., 1990 ) the total population of izsI-PYY sites is widely, but discretely, distributed in the rat brain, with high densities of labeling present, among other regions, in hippocampal and cortical areas. Using increasing concentrations of the selective Y, competitor [ProX4]-NPY, we confirmed and extended earlier findings Aicher et al., 1991) on the preferential localization of Y, receptors in the rat CNS. In addition to superficial laminar cortical areas above the rhinal nucleus, comparatively high levels of Y, sites are seen in the claustrum, the dentate gyrus of the hippocampal formation, and the reuniens nucleus of the thalamus. Lower but still detectable amounts ofY, sites are also present in various thalamic and hypothalamic nuclei.
The functional relevance of the Y, receptor class in the brain remains to be fully established. However, their concentrations in cortical areas suggest a modulatory role in the integration of cortical functions, especially since the cortex is enriched with NPY-like-immunoreactive materials (Chronwall et al., 1985; O'Donohue et al., 1985; DeQuidt and Emson, 1986a,b) . In that regard, it is of interest to note that direct injections of NPYlike peptides in cortical areas, through the activation of phosphoinositide turnover (Hinson et al., 1988; Widdowson and Halaris, 1990a) , can increase the respiratory quotient and food intake (McGregor et al., 1990) . Thus, cortical areas such as the sulcal prefrontal cortex, in association with hypothalamic nuclei (Stanley and Leibowitz, 1984; Stanley et al., 1985; Kalra et al., 1988 Kalra et al., , 1990 Jolicoeur et al., 199 1 b; Leibowitz and Alexander, 199 l) , can, via the stimulation of Y, receptors, modulate these behaviors in the rat. The possible functional role of Y, sites in other areas such as the dentate gyrus and the reuniens nucleus remains to be established. To date, most studies, especially those related to the hippocampus, have focused on Y,-enriched areas such as the stratum radiatum of the CA 1 (Colmers et al., 1987 (Colmers et al., , 1988 (Colmers et al., , 1991 or the pyramidal cell layer of the CA3 subfield (Monnet et al., 1992) . However, the recent cloning of the Y, receptor class (Eva et al., 1990; Herzog et al., 1992; Yee et al., 1992) should facilitate further evaluation of its precise role in the CNS, as well as reveal the mechanisms involved in the regulation of its expression. In other brain regions, we first assumed that the majority of lZ51-PYY binding represented labeling of the Y, subtype. This was based on the relatively high potencies of C-terminal fragments such as NPY,,.,, to compete for specific 1z51-PYY or lz51-NPY labeling Aicher et al., 199 1) . However, the more detailed analysis performed here using selected brain region homogenates clearly revealed the biphasic nature of the competition profiles, with Hill coefficients significantly lower than unity, even in the presence of a blocking concentration of the Y, agonist [Leu3',ProX4]-NPY (see Table 7 ). The biphasic nature of the competition curves could relate to the existence of a single class of NPY receptors (e.g., Y,) under different affinity states. This possibility has already been suggested for various preparations including the porcine hippocampus (Inui et al., 1988 (Inui et al., , 1989 , dorsal root ganglia , whole rat brain , and cervical vagus nerve (Carp and Smith, 199 1) . However, the fact that we observed markedly different ratios between the high-and lowaffinity components (K,,/K,,) for the selective Y, agonist [Leu31,Pro34]-NPY and the Y, fragment NPY,,.,, tends to support an alternate hypothesis, namely, the existence of further NPY receptor heterogeneity.
In support of this concept, some studies have already suggested the existence of either PP (Whitcomb et al., 1990; Adamo and Hazelwood, 199 1) or atypical NPY/u (Roman et al., 1989; Monnet et al., 1992) receptors for which both PYY and NPY demonstrate high affinities in the mammalian CNS. We are currently investigating these various possibilities using preferential ligands for each additional putative receptor class. Molecular information concerning the presence of Y, receptors in various brain regions and tissues should also help to clarify this issue, although the cloning of this receptor class has yet to be reported.
The widespread anatomical distribution of the "so-called" Y, receptors reported here suggests its important role(s) in the mediation of the biological effects induced by NPY and related peptides. Various CNS actions of this peptide family have already been characterized as belonging to this receptor class (see Dumont et al., 1992 , for a recent review). It remains to be established if, in fact, these effects demonstrate an identical pharmacological profile. This can only be achieved using an extensive series of selective NPY/PYY fragments and analogs. This should reveal the possible functional heterogeneity of the now broadly classified Y, receptor class.
It is also of interest that NPY,.,, appears to be relatively more potent in competing for 1Z51-PYY binding in regions such as the olfactory bulb and the cerebellum.
This may relate to the existence in these areas of an atypical site, which possesses a high affinity for the full NPY sequence as well as the NPY,,, fragment, an observation already reported in regard to the effects of NPY and homologs on feeding behaviors (Magdalin et al., 1989; Jolicoeur et al., 1991b) .
In summary, Y, and Y, receptor subtypes are discretely, but differentially, distributed in the rat brain. Y, sites are especially concentrated in cortical areas, in the dentate gyrus of the hippocampal formation, and in a few other nuclei, while Y, binding sites are more broadly distributed, being enriched in most regions.
Moreover, it appears that sites classified as Y, receptors may constitute a heterogeneous population ofreceptors. Experiments are currently in progress to investigate fully this possibility using subtype selective analogs and molecular biological approaches. This work may have an important impact on our understanding of the functional role of NPY and related peptides in the brain. 
